In vivo sustained release of siRNA from solid lipid nanoparticles.

Small interfering RNA (siRNA) is a highly potent drug in gene-based therapy with a challenge of being delivered in a sustained manner. Nanoparticle drug delivery systems allow for incorporating and controlled release of therapeutic payloads. We demonstrate that solid lipid nanoparticles can incorporate and provide sustained release of siRNA. Tristearin solid lipid nanoparticles, made by nanoprecipitation, were loaded with siRNA (4.4-5.5 wt % loading ratio) using a hydrophobic ion pairing approach that employs the cationic lipid DOTAP. Intradermal injection of these nanocarriers in mouse footpads resulted in prolonged siRNA release over a period of 10-13 days. In vitro cell studies showed that the released siRNA retained its activity. Nanoparticles developed in this study offer an alternative approach to polymeric nanoparticles for encapsulation and sustained delivery of siRNA with the advantage of being prepared from physiologically well-tolerated materials.

[1]  O. Farokhzad,et al.  Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. , 2011, Angewandte Chemie.

[2]  Daniel G. Anderson,et al.  Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery , 2011, Proceedings of the National Academy of Sciences.

[3]  A. Louie,et al.  Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging. , 2011, Bioconjugate chemistry.

[4]  H. Wong,et al.  Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization. , 2011, Biomaterials.

[5]  E. Peira,et al.  Peptide-Loaded Solid Lipid Nanoparticles Prepared through Coacervation Technique , 2011 .

[6]  G. P. Agrawal,et al.  Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[7]  R. Zare,et al.  Sustained release of nucleic acids from polymeric nanoparticles using microemulsion precipitation in supercritical carbon dioxide. , 2010, Chemical communications.

[8]  R. Zare,et al.  Biodegradable nanoparticles with sustained release of functional siRNA in skin. , 2010, Journal of pharmaceutical sciences.

[9]  D. Leake,et al.  Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  Jeong Won Lee,et al.  Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.

[11]  T. Segura,et al.  siRNA applications in nanomedicine. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[12]  N. Zhang,et al.  Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages , 2010, Pharmaceutical Research.

[13]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[14]  Peixuan Guo,et al.  Engineering RNA for Targeted siRNA Delivery and Medical Application , 2010, Advanced Drug Delivery Reviews.

[15]  R. Pierce,et al.  Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo , 2009, Nucleic acids research.

[16]  Eben Alsberg,et al.  Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. , 2009, Journal of the American Chemical Society.

[17]  G. Kino,et al.  siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model , 2009, Gene Therapy.

[18]  Jiesheng Ye,et al.  Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery , 2009, Nanotechnology.

[19]  R. Juliano,et al.  Biological barriers to therapy with antisense and siRNA oligonucleotides. , 2009, Molecular pharmaceutics.

[20]  W. Mark Saltzman,et al.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA , 2009, Nature materials.

[21]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[22]  Jayanth Panyam,et al.  Polymeric nanoparticles for siRNA delivery and gene silencing. , 2009, International journal of pharmaceutics.

[23]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[24]  D. Leake,et al.  Stability study of unmodified siRNA and relevance to clinical use. , 2008, Oligonucleotides.

[25]  Junxian Yun,et al.  Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction , 2008 .

[26]  F. Hirayama,et al.  Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA. , 2008, Journal of pharmaceutical sciences.

[27]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[28]  T. Sauerbruch,et al.  1,2-Dioleoyl-3-Trimethylammonium-Propane (DOTAP)-Formulated, Immune-Stimulatory Vascular Endothelial Growth Factor A Small Interfering RNA (siRNA) Increases Antitumoral Efficacy in Murine Orthotopic Hepatocellular Carcinoma with Liver Fibrosis , 2008, Molecular medicine.

[29]  Yuhan Lee,et al.  Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. , 2008, Molecular pharmaceutics.

[30]  D. Leake,et al.  Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. , 2008, The Journal of investigative dermatology.

[31]  A. Judge,et al.  Overcoming the innate immune response to small interfering RNA. , 2008, Human gene therapy.

[32]  A. Almeida,et al.  Solid lipid nanoparticles as a drug delivery system for peptides and proteins. , 2007, Advanced drug delivery reviews.

[33]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[34]  A. Parker,et al.  Delivery of RNA Interference , 2006, Cell cycle.

[35]  J. Lieberman,et al.  Knocking down Disease with siRNAs , 2006, Cell.

[36]  H. Kristensen,et al.  Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  A. Aigner,et al.  RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.

[38]  Mayank M. Patel,et al.  Degradation kinetics of high molecular weight poly(L-lactide) microspheres and release mechanism of lipid:DNA complexes. , 2004, Journal of pharmaceutical sciences.

[39]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[40]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[41]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.